Inflammatory conditions are a rare cause of aortic aneurysms, accounting for 3% to 10% of cases. Patients with ankylosing spondylitis uncommonly present with ascending aortic aneurysms related to long-standing, aggressive disease. We review the case of a young man with ankylosing spondylitis exhibiting complex inflammatory aortic aneurysms atypically involving the abdominal and descending thoracic aorta, as well as ectasia of medium-sized visceral vessels. Inflammatory aneurysms require a multidisciplinary approach incorporating diagnostic modalities to confirm etiology, targeted immunosuppressive therapy to control disease activity, and aneurysm repair. Evidence suggests that endovascular approaches should be considered first-line therapy for patients requiring reconstruction when anatomy is appropriate. (J Vasc Surg 2017;66:600-4.) An underlying inflammatory disorder is associated with 3% to 10% of aortic aneurysms. The most common cardiovascular complications of AS include aortic insufficiency, conduction system disease, and aortitis. 5 AS-associated aortitis was first documented in the 1930s. 6 Multiple case reports now exist documenting that cardiovascular manifestations occur in 2% to 18% of patients with AS. 5,7 Aortitis with AS typically occurs late in the course of aggressive disease, preferentially affecting the ascending aorta. 5 Owing to the rare nature of this condition, the optimal management of patients with AS-related IAAs remains relatively unknown. 8 We report an atypical case of IAA in a young man with AS exhibiting multifocal aortic aneurysms and ectasia of medium-sized arteries. The patient has consented to the publication of this case report.
The most common cardiovascular complications of AS include aortic insufficiency, conduction system disease, and aortitis. 5 AS-associated aortitis was first documented in the 1930s. 6 Multiple case reports now exist documenting that cardiovascular manifestations occur in 2% to 18% of patients with AS. 5, 7 Aortitis with AS typically occurs late in the course of aggressive disease, preferentially affecting the ascending aorta. 5 Owing to the rare nature of this condition, the optimal management of patients with AS-related IAAs remains relatively unknown. 8 We report an atypical case of IAA in a young man with AS exhibiting multifocal aortic aneurysms and ectasia of medium-sized arteries. The patient has consented to the publication of this case report.
CASE REPORT
A 34-year-old man with AS was seen by his family physician for a 4-month history of central, crampy abdominal pain that had increased in severity progressively. There was no associated nausea or vomiting and his bowel habits had remained normal.
His only medication was occasional use of nonsteroidal antiinflammatory agents for symptom control of sacroiliitis-related back pain. His family history was significant for genetically 
DISCUSSION
IAAs are an uncommon cause of aortic aneurysms and have been related classically to giant cell arteritis or Takayasu arteritis. 9 AS is a less common etiology for IAA and typically occurs late in the course for older patients with aggressive disease. 9 The age of our patient, the increased inflammatory markers, the history of rheumatologic disease, and the diffuse vascular involvement on positron emission tomography-CT all supported the diagnosis of an underlying inflammatory disorder in our case. Aneurysm formation can occur in 15% of patients with Takayasu arteritis ("pulseless disease"), but rarely in the absence of concurrent arterial stenoses or occlusions. 10 The patient's age and the lack of ascending aortic involvement ruled out giant cell arteritis and was atypical for AS-related aortitis. 5 The patient also had normal serum immunoglobulin levels rendering a diagnosis of immunoglobulin G4-related lymphoplasmacytic aortitis unlikely. 11 The first reported association of Takayasu arteritis and AS was in 1966. 12 A review of 114 Takayasu arteritis patients found eight cases of associated AS. 13 Our patient has a necrotizing large vessel vasculitis with granulomatous lymphadenopathy affecting the descending thoracic and abdominal aorta of unclear etiology in association with a diagnosis of AS.
The optimal management of IAA, particularly in the presence of active inflammation, is unclear. 8 Although the risk of rupture may be less in chronic, fibrotic IAAs, 14 the risk may be greater in patients with active inflammation, particularly in the setting of rheumatologic conditions such as AS, necessitating urgent therapy. Current guidelines suggest that initial therapy should include corticosteroid administration with delayed elective repair to allow the acute inflammatory process to resolve. 2 Corticosteroid therapy, however, can impair wound healing, and does not impact the long-term outcomes for treatment significantly, contributing to the difficulties in determining the optimal timing for surgical repair. 8 In this case, and after consultation with our colleagues in rheumatology, we felt the potential benefits with respect to decreasing tissue friability would offset the potential risks. The most appropriate surgical management of IAA remains a topic of debate. Early reports suggested that endovascular repair was associated with aortic inflammation and exacerbation of periaortitis and fibrosis, which could worsen potentially the underlying pathophysiology of IAA. 15, 16 Although these cases occurred in patients with inflammatory aneurysms of unknown etiology, perpetuation of inflammation would be a significant concern in patients with active aortitis. However, the presence of actively inflamed, friable aortic tissue also complicates open repair, although successful repair has been described previously in patients without an active vasculitic process. 17 Typically, endovascular repair is avoided in young patients less than 60 years of age owing to concerns around the long-term durability of endovascular repair. We elected to pursue endovascular repair in this patient because of the intense inflammation noted on positron emission tomography-CT imaging, the associated abdominal pain, and the large size of the multiple abdominal and thoracic aneurysms.
In fact, postoperative biopsies of the aortic wall demonstrated severe necrotizing aortitis that would have prevented safe aortic closure had open repair been used as the initial treatment modality. Small cohort studies have suggested that endovascular repair of IAA leads to greater decreases in aneurysm size and fewer complications compared with open repair. 18 Systematic reviews have also suggested the endovascular repair is associated with better short-term outcomes. 19 Although longterm complications from this approach have been described, they have been related to recurrence of the underlying inflammatory disorder. 20, 21 Endovascular repair should likely be considered first-line therapy for anatomically appropriate patients with IAAs, particularly in the setting of an underlying rheumatologic disorder.
CONCLUSIONS
IAA requires a multidisciplinary approach incorporating diagnostic modalities to confirm etiology, immunosuppressive therapy to control disease activity, and surgical therapy for aneurysm repair. Patients with underlying rheumatologic conditions may present with atypical features, or atypical anatomic aortic involvement, and present unique diagnostic and/or therapeutic challenges. 
